Recacha Esther, Delgado-Valverde Mercedes, Pulido Marina R, Pérez-Nadales Elena, Pérez-Palacios Patricia, Portillo-Calderón Inés, Sánchez-Calvo Juan Manuel, Gracia-Ahufinger Irene, Pascual Álvaro
Unidad de Gestión Clínica de Enfermedades Infecciosas y Microbiología, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Instituto de Biomedicina de Sevilla/Hospital Virgen Macarena, Universidad de Sevilla/CSIC, Sevilla, Spain.
Microbiol Spectr. 2025 Jul;13(7):e0233824. doi: 10.1128/spectrum.02338-24. Epub 2025 May 23.
ST147 has emerged as a successful clone able to efficiently disseminate a number of carbapenemases, including . This study compared a representative -carrying plasmid of an ST147 clone with plasmids that usually harbor belonging to the high-risk clone ST512. Five clinical isolates of KPC-3-producing belonging to ST147 isolated in Southern Spain were analyzed. The first ST147 isolate detected was compared with two previous isolates of ST512/KPC-3 and KPC-3-encoding plasmid pKpQIL as reference plasmid. Microdilution, disk diffusion, β-CARBA test, and NG-Test CARBA 5 were used for antimicrobial susceptibility analysis and phenotypic characterization of the isolates according to EUCAST guidelines. Molecular characterization was performed using pulsed-field gel electrophoresis (PFGE)-I, sequenced (by Illumina and Oxford Nanopore) and annotated with open-source databases (CGE tools and RAST). Plasmid incompatibility groups were analyzed using PlasmidFinder; BRIG was used to compare the -harboring plasmids from three of the selected clinical isolates with each other and with pKpQIL. Clinical isolates of ST147/KPC-3 showed resistance to β-lactams, fluoroquinolones, and aminoglycosides. Clinical isolates ST147/KPC-3 and ST512/KPC-3 had identical PFGE patterns in each clone. Plasmid replicon analysis showed a plasmid with the formula IncFII (K2:A-:B-) in the ST512 isolates, identical to pKpQIL; the ST147 isolates harbored IncFII (K1:A-:B-), although the genetic environment of was the same as pKpQIL, which is Tn_IS upstream of and IS downstream of . Plasmids harboring in ST147 and ST512 are different, although differences are subtle. The genetic environment of in the different sequence types is very conservative and identical to pKpQIL.IMPORTANCEThe successful spread of is primarily due to the dissemination of isolates belonging to high-risk clonal complex 258 (ST258, ST11, and ST512); however, new clones are emerging globally as the ST147 clone. In this study, we compare the genetic environment of a representative -carrying plasmid of an ST147 clone with plasmids that usually harbor belonging to the high-risk clone ST512. Plasmids harboring detected in ST512 and ST147 were different; however, the close genetic environments of in the different plasmids (ST147 and ST512) remained conserved.
ST147已成为一个成功的克隆菌株,能够有效传播多种碳青霉烯酶,包括……本研究将ST147克隆菌株携带碳青霉烯酶的代表性质粒与通常携带属于高风险克隆ST512的碳青霉烯酶的质粒进行了比较。分析了在西班牙南部分离出的5株属于ST147的产KPC-3的临床分离株。将检测到的第一株ST147分离株与之前两株ST512/KPC-3分离株以及编码KPC-3的质粒pKpQIL作为参考质粒进行比较。根据欧盟CAST指南,采用微量稀释法、纸片扩散法、β-内酰胺酶检测试验(β-CARBA test)和NG-Test CARBA 5对分离株进行抗菌药物敏感性分析和表型特征鉴定。使用脉冲场凝胶电泳(PFGE)-I进行分子特征分析,进行测序(通过Illumina和牛津纳米孔技术)并使用开源数据库(CGE工具和RAST)进行注释。使用质粒分型工具(PlasmidFinder)分析质粒不相容群;使用BRIG将所选三株临床分离株中携带碳青霉烯酶的质粒相互之间以及与pKpQIL进行比较。ST147/KPC-3临床分离株对β-内酰胺类、氟喹诺酮类和氨基糖苷类药物耐药。临床分离株ST147/KPC-3和ST512/KPC-3在每个克隆中具有相同的PFGE图谱。质粒复制子分析显示,ST512分离株中的一个质粒的模式为IncFII(K2:A-:B-),与pKpQIL相同;ST147分离株携带IncFII(K1:A-:B-),尽管碳青霉烯酶的基因环境与pKpQIL相同,即碳青霉烯酶上游是Tn_IS,下游是IS。ST147和ST512中携带碳青霉烯酶的质粒不同,尽管差异细微。不同序列类型中碳青霉烯酶的基因环境非常保守,且与pKpQIL相同。
碳青霉烯酶的成功传播主要归因于属于高风险克隆复合体258(ST258、ST11和ST512)的碳青霉烯酶分离株的传播;然而,作为ST147克隆菌株,新的克隆菌株正在全球出现。在本研究中,我们将ST147克隆菌株携带碳青霉烯酶的代表性质粒的基因环境与通常携带属于高风险克隆ST512的碳青霉烯酶的质粒进行了比较。在ST512和ST147中检测到的携带碳青霉烯酶的质粒不同;然而,不同质粒(ST147和ST512)中碳青霉烯酶的紧密基因环境仍然保守。